Companies / Ani Pharmaceuticals Inc / Activity
Activity — Ani Pharmaceuticals Inc
84 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | Lalwani Nikhil CEO | Grant | Common Stock | $5.83M | +76K +21.08% | 434,166 1.89% of shares | low |
| May 11, 2026 | Lalwani Nikhil CEO | Sell | Common Stock | $4.27M | -55K -13.58% | 349,889 1.52% of shares | medium |
| Feb 11, 2026 | Lalwani Nikhil CEO | Other | Common Stock | $2.34M | -31K -7.46% | 380,560 1.66% of shares | low |
| Feb 26, 2026 | Carey Stephen P. Executive | Grant | Common Stock | $1.72M | +22K +13.07% | 192,316 0.84% of shares | low |
| Feb 26, 2026 | Mutz Christopher Executive | Grant | Common Stock | $1.64M | +21K +25.11% | 106,146 0.46% of shares | low |
| Mar 7, 2026 | Lalwani Nikhil CEO | Other | Common Stock | $1.26M | -17K -4.04% | 404,889 1.76% of shares | low |
| Feb 26, 2026 | Cook Meredith Executive | Grant | Common Stock | $1.07M | +14K +20.57% | 81,445 0.35% of shares | low |
| Feb 26, 2026 | Gutwerg Ori Executive | Grant | Common Stock | $1.00M | +13K +17.04% | 89,063 0.39% of shares | low |
| Feb 28, 2026 | Lalwani Nikhil CEO | Other | Common Stock | $902.8K | -12K -2.81% | 421,949 1.84% of shares | low |
| Feb 12, 2026 | Lalwani Nikhil CEO | Other | Common Stock | $896.5K | -12K -3.07% | 368,872 1.61% of shares | low |
| Feb 26, 2026 | Gassert Chad Executive | Grant | Common Stock | $857.6K | +11K +16.84% | 77,137 0.34% of shares | low |
| Feb 26, 2026 | Shanmugam Muthusamy Executive | Grant | Common Stock | $857.6K | +11K +12.36% | 101,056 0.44% of shares | low |
| Feb 26, 2026 | Davis Krista Executive | Grant | Common Stock | $834.0K | +11K +21.94% | 60,073 0.26% of shares | low |
| May 13, 2026 | Walsh Patrick D Director | Sell | Common Stock | $806.3K | -10K -20.65% | 38,432 0.17% of shares | medium |
| Feb 14, 2026 | Lalwani Nikhil CEO | Other | Common Stock | $796.7K | -10K -2.79% | 358,574 1.56% of shares | low |
| Feb 12, 2026 | Mutz Christopher Executive | Sell | Common Stock | $538.3K | -7K -7.06% | 92,566 0.40% of shares | medium |
| Feb 26, 2026 | Rowland Thomas Andrew Executive | Grant | Common Stock | $464.5K | +6K +15.80% | 44,130 0.19% of shares | low |
| Mar 3, 2026 | Walsh Patrick D Director | Sell | Common Stock | $445.4K | -6K -10.27% | 52,405 0.23% of shares | medium |
| Feb 11, 2026 | Carey Stephen P. Executive | Other | Common Stock | $419.6K | -6K -3.04% | 175,360 0.76% of shares | low |
| Feb 20, 2026 | Mutz Christopher Executive | Sell | Common Stock | $415.3K | -5K -5.90% | 84,840 0.37% of shares | medium |
| Mar 7, 2026 | Carey Stephen P. Executive | Other | Common Stock | $381.3K | -5K -2.78% | 180,393 0.79% of shares | low |
| Mar 9, 2026 | Davis Krista Executive | Sell | Common Stock | $377.1K | -5K -8.92% | 51,946 0.23% of shares | medium |
| Mar 11, 2026 | Rowland Thomas Andrew Executive | Sell | Common Stock | $357.5K | -5K -10.97% | 38,730 0.17% of shares | medium |
| Feb 11, 2026 | Mutz Christopher Executive | Other | Common Stock | $346.6K | -5K -4.24% | 102,771 0.45% of shares | low |
| Feb 11, 2026 | Gassert Chad Executive | Other | Common Stock | $325.5K | -4K -5.80% | 69,346 0.30% of shares | low |
| Feb 11, 2026 | Gutwerg Ori Executive | Other | Common Stock | $325.4K | -4K -5.08% | 79,757 0.35% of shares | low |
| May 11, 2026 | Walsh Patrick D Director | Sell | Common Stock | $320.8K | -4K -7.58% | 48,432 0.21% of shares | medium |
| Mar 5, 2026 | Carey Stephen P. Executive | Sell | Common Stock | $302.2K | -4K -2.11% | 185,543 0.81% of shares | medium |
| Mar 9, 2026 | Mutz Christopher Executive | Sell | Common Stock | $267.2K | -4K -3.67% | 94,471 0.41% of shares | medium |
| Jun 5, 2026 | Carey Stephen P. Executive | Sell | Common Stock | $265.0K | -3K -1.80% | 180,393 0.79% of shares | medium |
| Mar 5, 2026 | Carey Stephen P. Executive | Sell | Common Stock | $249.8K | -3K -1.72% | 189,543 0.83% of shares | medium |
| Mar 7, 2026 | Mutz Christopher Executive | Other | Common Stock | $245.4K | -3K -3.27% | 98,073 0.43% of shares | low |
| Mar 7, 2026 | Gutwerg Ori Executive | Other | Common Stock | $245.4K | -3K -3.91% | 81,468 0.35% of shares | low |
| Feb 12, 2026 | Mutz Christopher Executive | Other | Common Stock | $243.4K | -3K -3.09% | 99,598 0.43% of shares | low |
| Jun 29, 2026 | Carey Stephen P. Executive | Sell | Common Stock | $239.7K | -3K -1.58% | 177,543 0.77% of shares | medium |
| Feb 11, 2026 | Davis Krista Executive | Other | Common Stock | $230.0K | -3K -5.15% | 55,547 0.24% of shares | low |
| Feb 11, 2026 | Cook Meredith Executive | Other | Common Stock | $229.6K | -3K -4.05% | 71,363 0.31% of shares | low |
| Mar 13, 2026 | Mutz Christopher Executive | Sell | Common Stock | $226.5K | -3K -3.35% | 91,309 0.40% of shares | medium |
| Feb 11, 2026 | Shanmugam Muthusamy Executive | Other | Common Stock | $221.0K | -3K -3.12% | 89,940 0.39% of shares | low |
| May 12, 2026 | Gutwerg Ori Executive | Sell | Common Stock | $220.4K | -3K -3.40% | 78,696 0.34% of shares | medium |
| Feb 12, 2026 | Carey Stephen P. Executive | Other | Common Stock | $217.0K | -3K -1.61% | 172,531 0.75% of shares | low |
| Feb 28, 2026 | Carey Stephen P. Executive | Other | Common Stock | $204.9K | -3K -1.44% | 189,543 0.83% of shares | low |
| Feb 14, 2026 | Carey Stephen P. Executive | Other | Common Stock | $189.4K | -2K -1.42% | 170,083 0.74% of shares | low |
| Feb 14, 2026 | Mutz Christopher Executive | Other | Common Stock | $185.9K | -2K -2.60% | 90,163 0.39% of shares | low |
| Feb 28, 2026 | Mutz Christopher Executive | Other | Common Stock | $164.1K | -2K -2.09% | 103,925 0.45% of shares | low |
| Feb 28, 2026 | Gutwerg Ori Executive | Other | Common Stock | $164.1K | -2K -2.49% | 86,842 0.38% of shares | low |
| Feb 28, 2026 | Gassert Chad Executive | Other | Common Stock | $164.1K | -2K -2.88% | 74,916 0.33% of shares | low |
| Jun 5, 2026 | Carey Stephen P. Executive | Exercise | Common Stock | $164.0K | +3K +1.84% | 183,705 0.80% of shares | low |
| Mar 5, 2026 | Carey Stephen P. Executive | Exercise | Common Stock | $164.0K | +3K +1.75% | 192,855 0.84% of shares | low |
| Jun 8, 2026 | Haughey Thomas Director | Sell | Common Stock | $161.8K | -2K -4.89% | 38,878 0.17% of shares | medium |